
Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.
Novel Chemotherapy Benefit Index for Advanced Ovarian Cancer: Key Genes, Survival Rates, and Immunotherapy Insights ππ








